Trial intelligence / Profile preview

Chromoendoscopy versus conventional endoscopy in patients with polyposis syndrome

2014-003546-27Phase 3Completed

Sponsor
Universitätsklinikum Bonn
Start
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of indigotindisulfonate sodium in Colonic Adenomatous Polyposis (2 arms), sponsored by Universitätsklinikum Bonn. Primary endpoint: Polyp detection rate. Started Feb 2016; status: completed.

02

Drugs

indigotindisulfonate sodium
03

Conditions

Colonic Adenomatous Polyposis

Beyond the preview

Go deeper on 2014-003546-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-003546-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call